ARVN FY 2020 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$907M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$26M-39.7% YoY

Gross Profit

$26M100.0% margin

Operating Income

-$121M-466.4% margin

Net Income

-$119M-460.6% margin

EPS (Diluted)

$-3.02

Cash Flow

Operating Cash Flow

-$90M

Free Cash Flow

-$96M

Stock-Based Comp.

$30M

Balance Sheet

Total Assets

$717M

Total Liabilities

$75M

Stockholders' Equity

$642M

Cash & Equivalents

$588M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$26M	$43M	-39.7%
Gross Profit	$26M	$43M	-39.7%
Operating Income	-$121M	-$52M	-134.5%
Net Income	-$119M	-$70M	-69.7%